Tag: Malin
News alerts
Latest content
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb

- Kainova expands DT 7012 trial into Europe

- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease

- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment

- FDA approves new high dose Spinraza regimen for SMA

Contact details
PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
